Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical Activity of the Type II CD20 Antibody GA101 (... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models
0
Authors
Sylvia Herter
21 more
Sylvia Herter
•
Frank Herting
19 more
•
Christian Klein
Published
July 20, 2013
Paper
Conversation
0
Reviews
0
Bounties
0
Loading PDF viewer…
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Molecular Cancer Therapeutics
Topics
Biology
Cancer Oncology
Medicine
Immunology
Radiology, Nuclear Medicine And Imaging
Show all topics
DOI
10.1158/1535-7163.mct-12-1182
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Molecular Cancer Therapeutics
Topics
Biology
Cancer Oncology
Medicine
Immunology
Radiology, Nuclear Medicine And Imaging
Show all topics
DOI
10.1158/1535-7163.mct-12-1182
Other Formats
PDF
